COMPARATIVE CLINICAL STUDY OF POLYHERBAL FORMULATION FOR IBS-C: RANDOMISED, THREE-ARM, OPEN-LABEL CLINICAL TRIAL
INDIAN DRUGS · 28.07.2026 · 63 (07) · 54-64
DOI: 10.53879/id.63.07.15472 ↗Kurz gefasst
Fachartikel in der Zeitschrift INDIAN DRUGS, online erschienen am 05.08.2026. Verfasst von Ashwin D. Porwal und 4 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a gastrointestinal disorder marked by abdominal pain, bloating, and altered bowel habits, affecting 4.2%-7.5% of the Indian population. The constipation-predominant subtype (IBS-C) poses significant management challenges, prompting interest in alternative therapies. This study evaluated the safety and efficacy of a polyherbal formulation, the IBS SureTM tablet, compared to a placebo and mesalamine tablet in 60 IBS-C patients diagnosed using ROMEIV criteria. Participants were randomly divided into three groups of 20 each: IBS SureTM tablet, placebo, and mesalamine. Over three weeks, the IBS SureTM tablet group demonstrated significant improvement in complete spontaneous bowel movements (85.0%) compared to placebo (4.0%) and mesalamine (60.0%). Additionally, the IBS SureTM tablet group showed the greatest reduction in abdominal pain, bloating, stool consistency issues, and straining intensity, along with the highest treatment satisfaction. These findings highlight the IBS SureTM tablet as an effective, well-tolerated intervention for managing IBS-C symptoms.
Zitieren
APA
Porwal, A. D., Gandhi, P. M., Kulkarni, D. K., Bhagwat, G. B., & Kamble, P. P. (2026). COMPARATIVE CLINICAL STUDY OF POLYHERBAL FORMULATION FOR IBS-C: RANDOMISED, THREE-ARM, OPEN-LABEL CLINICAL TRIAL. INDIAN DRUGS, 63(07), 54-64. https://doi.org/10.53879/id.63.07.15472
Vancouver
Porwal AD, Gandhi PM, Kulkarni DK, Bhagwat GB, Kamble PP. COMPARATIVE CLINICAL STUDY OF POLYHERBAL FORMULATION FOR IBS-C: RANDOMISED, THREE-ARM, OPEN-LABEL CLINICAL TRIAL. INDIAN DRUGS. 2026;63(07):54-64. doi:10.53879/id.63.07.15472
BibTeX
@article{Porwal2026,
author = {Porwal, Ashwin D. and Gandhi, Paresh M. and Kulkarni, Deepak K. and Bhagwat, Gajanan B. and Kamble, Pravin P.},
title = {COMPARATIVE CLINICAL STUDY OF POLYHERBAL FORMULATION FOR IBS-C: RANDOMISED, THREE-ARM, OPEN-LABEL CLINICAL TRIAL},
journal = {INDIAN DRUGS},
year = {2026},
volume = {63},
number = {07},
pages = {54--64},
doi = {10.53879/id.63.07.15472}
}
EUVIMED